Dexcom (DXCM) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Circular Clean Climate Climate Change Contaminant Coral Ecosystem Environment Environmental Extreme Weather Forest Intensity Leach Life Cycle Lifecycle Materials Natural Resources Nature Offset Package Packaging Pandemic Plastic Raw Materials Waste Water Access Affordability African American Asian Attrition Benefits Black California Consumer Privacy Act Citizenship Collective Bargaining Community Culture Customer Customer Satisfaction Cyber Cybersecurity Data Privacy Data Security Death Demographic Demographics Disability Diversity Employee Employee Engagement Employee Resource Group Employee Retention Engagement Ethnic Ethnicity Frontline Workers Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Injury Latinx LGBTQ Minority Pay Equity Pay for Performance Pay Parity Perquisites Privacy Product Quality Recall Recruit Reimbursement Retention Retirement Safety Satisfaction Skilled Skills Social Stakeholder Supplier Supply Chain Supply Chain Management Talent Training Union Volunteer Women Workers Workforce Workplace Safety Anti-corruption Assessment Assurance Attorneys General Audit Board Evaluation Bonus Bribery Chronic Classified Clawback Commitment Conflict of Interest Corporate Governance Corporate Purpose Corporate Social Responsibility Corruption Department of Enterprise Risk Management ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovate Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Materiality Mission Oversee Oversight Perquisite Pledging Procurement Proxy Access Proxy Contest Purpose Quality Standard R&D Reputation Reputational Research and Development Responsibility Responsible Self-evaluation Special Meeting Strategy Sustainability Sustainable Targets Tax Tenure Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

(a) Proxies for DexCom’s Annual Meeting of Stockholders (the “Annual Meeting”) were solicited pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended. At the close of business on the record date, there were 96,705,867 shares outstanding and entitled to vote and 86,703,748 shares were voted online, via telephone or by proxy on the matters described below.
(b) The matters described below were voted on at the Annual Meeting and the number of votes cast with respect to each matter was as indicated:
(1) Holders of DexCom’s common stock voted to elect three Class I directors, each to serve until the DexCom’s 2024 Annual Meeting of Stockholders and until their successor has been elected and qualified, or until their earlier death, resignation or removal as follows:


Name	For	Against	Abstentions	Broker Non- Votes
Kevin R. Sayer	78,775,266	2,986,211	345,953	4,596,317
Nicholas Augustinos	68,863,671	13,203,637	40,123	4,596,317
Bridgette P. Heller	81,245,908	822,669	38,854	4,596,317

(2) Holders of DexCom’s common stock voted to ratify the selection by the Audit Committee of the Board of Directors for the appointment of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2021:


		Number of Shares
Shares Voted in Favor:		83,456,097
Shares Voted Against:		3,211,326
Shares Abstaining:		36,325

(3) Holders of DexCom’s common stock voted to approve the non-binding vote on an advisory resolution on compensation paid to DexCom’s named executive officers, as disclosed pursuant to